Free Stipulation - District Court of Delaware - Delaware

Case 1:08-cv-00112-SLR

Document 15

Filed 03/31/2008

Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE, Plaintiff, v. BARR PHARMACEUTICALS, INC. and BARR LABORATORIES, INC., Defendants. ) ) ) ) ) ) ) ) ) ) )

C.A. No. 08-112 (SLR)

STIPULATION AND ORDER OF DISMISSAL OF COMPLAINT AGAINST BARR PHARMACEUTICALS, INC. Plaintiff SmithKline Beecham Corp. d/b/a GlaxoSmithKline ("GSK") and Defendants Barr Laboratories, Inc. ("Barr Labs") and Barr Pharmaceuticals, Inc. ("Barr Pharmaceuticals") hereby stipulate to dismiss the Complaint as filed by GSK against Defendant Barr Pharmaceuticals. The action will continue against Defendant Barr Labs. It is further stipulated that this dismissal is without prejudice and subject to the following conditions: 1. Barr Pharmaceuticals agrees to be bound by the Judgment and any Orders

or decisions in the above-captioned action regarding the infringement, validity and/or enforceability of U.S. Patent Nos. 5,565,467, 5,846,976 and 5,998,427 ("the Patents-in-Suit") and any Order in the above-captioned action granting preliminary or permanent injunctive relief against Barr Labs. Barr Pharmaceuticals stipulates to be bound, in any subsequent action or proceeding involving the Patents-in-Suit between GSK and Barr Labs or Barr Pharmaceuticals, by the Judgment and any Orders or decisions made in the above-captioned action to the same extent Barr Labs would be bound as a party to the above-captioned action. 2. Barr Pharmaceuticals agrees to provide documents, witnesses and

information in its possession, custody or control for the purposes of the above-captioned action

Case 1:08-cv-00112-SLR

Document 15

Filed 03/31/2008

Page 2 of 2

to the same extent Barr Pharmaceuticals would be required to do if it were to remain a party to this action. 3. The motion to dismiss the Complaint filed by Barr Pharmaceuticals on

March 17, 2008 is hereby withdrawn. 4. The caption shall be amended to read: SmithKline Beecham Corporation

d/b/a GlaxoSmithKline v. Barr Laboratories, Inc., C. A. No. 08-112 (SLR).

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

PHILLIPS, GOLDMAN & SPENCE, P.A.

/s/ Jack B. Blumenfeld
Jack B. Blumenfeld (#1014) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] Attorneys for Plaintiff SmithKline Beecham Corp. d/b/a GlaxoSmithKline Of Counsel: Evan R. Chesler Keith R. Hummel David Greenwald CRAVATH, SWAINE & MOORE LLP Worldwide Plaza 825 Eighth Avenue New York, NY 10019 (212) 474-1000

/s/ John C. Phillips, Jr.
John C. Phillips, Jr. (#110) Brian E. Farnan (#4089) 1200 North Broom Street Wilmington, DE 19806 (302) 655-4200 [email protected] Attorneys for Defendants Barr Pharmaceuticals, Inc. and Barr Laboratories, Inc. Of Counsel: George C. Lombardi James M. Hilmert Ivan M. Poullaos WINSTON & STRAWN LLP 35 West Wacker Drive Chicago, IL 60601 (312) 448-5600

SO ORDERED this ______ day of _________, 2008

United States District Court Judge

2